CLINICAL_TRIALS
research
· 2026-03-23
Clinical Trial Update: RIG 101 Trial in Healthy Adults and Adults With Asthma [Phase 1, Phase 2]
Summary
RIGImmune Inc. reports that the Phase 1/2 trial of RIG 101 in healthy adults and adults with asthma is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: RIGImmune Inc. | Conditions: Healthy Adult Participants, Asthma Exacerbation | Phase 1, Phase 2 | Status: RECRUITING